These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12511533)

  • 61. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
    Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
    Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.
    Angeli F; Verdecchia P; Angeli E; Poeta F; Sardone M; Bentivoglio M; Prosciutti L; Cocchieri M; Zollino L; Bellomo G; Rondoni F; Garognoli O; Lenti S; Frigerio C; Gattobigio R; Benemio G; Biscottini B; Panciarola R; Buccolieri M; Liberati R; Trottini M; Cipollini F; Gemelli F; Schillaci G; Porcellati C
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):812-6. PubMed ID: 17060807
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Value of the electrocardiographic Cornell criteria for detecting left ventricular hypertrophy in elderly men].
    Zeng XZ; Liu DP; He Q; Guo HL; Fang F; Liu DG; Dong R; Zeng HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):56-8. PubMed ID: 19671355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Usefulness of QRS voltage correction by body mass index to improve electrocardiographic detection of left ventricular hypertrophy in patients with systemic hypertension.
    Angeli F; Verdecchia P; Iacobellis G; Reboldi G
    Am J Cardiol; 2014 Aug; 114(3):427-32. PubMed ID: 24934758
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL; Grodzicki T; Beevers DG; Webster J; Jokelainen JJ; Bulpitt CJ
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.
    Barrios V; Escobar C; Calderón A; Echarri R; Barrios S; Navarro-Cid J
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):168-73. PubMed ID: 19651760
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combination of electrocardiographic and echocardiographic information identifies individuals prone to a progressive increase in left ventricular mass over 5 years.
    Reffelmann T; Dörr M; Völzke H; Kors J; Ruppert J; Robinson D; Felix SB
    J Hypertens; 2009 Apr; 27(4):861-8. PubMed ID: 19262408
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Left ventricular hypertrophy in hemodialysis patient: Prevalence, electrocardiographic, echocardiographic study and associated risk factors].
    Chargui S; Allouche E; Dkhil W; Agrebi S; Ben Ahmed H; Ezzaouia K; Hajji M; Ezzamouri A; Basdah L; Ben Hamida F; Harzallah A; Abderrahim E
    Nephrol Ther; 2022 Jul; 18(4):247-254. PubMed ID: 35078738
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Variability and concordance of Cornell and Sokolow-Lyon electrocardiographic criteria in hypertensive patients.
    Vinyoles E; Rodriguez-Blanco T; de la Figuera M; Colomé JM; Tafalla M; Calbet N; Fernández-San Martin MI; García-Alonso J; Murillo C; Agudo J
    Blood Press; 2012 Dec; 21(6):352-9. PubMed ID: 22587668
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
    Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
    Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Lindholm LH; Dahlöf B;
    Hypertension; 2007 Nov; 50(5):984-90. PubMed ID: 17893425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Am Coll Cardiol; 1996 Jan; 27(1):124-31. PubMed ID: 8522685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.
    Molloy TJ; Okin PM; Devereux RB; Kligfield P
    J Am Coll Cardiol; 1992 Nov; 20(5):1180-6. PubMed ID: 1401620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.